Signaturefd LLC Purchases 463 Shares of Metlife Inc (NYSE:MET)

Signaturefd LLC grew its position in Metlife Inc (NYSE:MET) by 7.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,413 shares of the financial services provider’s stock after buying an additional 463 shares during the period. Signaturefd LLC’s holdings in Metlife were worth $319,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Jackson Grant Investment Advisers Inc. boosted its holdings in shares of Metlife by 4,407.7% in the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 586 shares of the financial services provider’s stock valued at $25,000 after buying an additional 573 shares in the last quarter. Osborn Williams & Donohoe LLC bought a new stake in shares of Metlife in the 1st quarter valued at about $26,000. Meridian Wealth Management LLC purchased a new position in shares of Metlife in the 1st quarter valued at approximately $26,000. Advisory Alpha LLC purchased a new position in shares of Metlife in the 1st quarter valued at approximately $27,000. Finally, Coastal Capital Group Inc. purchased a new position in shares of Metlife in the 2nd quarter valued at approximately $30,000. Institutional investors and hedge funds own 75.13% of the company’s stock.

Shares of Metlife stock traded down $1.76 during midday trading on Wednesday, hitting $45.17. The company had a trading volume of 166,511 shares, compared to its average volume of 5,181,302. The stock has a market capitalization of $44.05 billion, a PE ratio of 8.39, a price-to-earnings-growth ratio of 0.99 and a beta of 1.09. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22. The business has a fifty day moving average price of $49.30. Metlife Inc has a 12-month low of $37.76 and a 12-month high of $51.16.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.07. Metlife had a net margin of 9.28% and a return on equity of 9.75%. The company had revenue of $16.45 billion during the quarter, compared to analyst estimates of $16.43 billion. During the same period last year, the firm posted $1.30 EPS. Metlife’s revenue for the quarter was down 22.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Metlife Inc will post 5.65 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Tuesday, August 6th will be given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 3.90%. The ex-dividend date is Monday, August 5th. Metlife’s dividend payout ratio is presently 32.65%.

Several equities analysts recently commented on MET shares. Zacks Investment Research raised shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price objective for the company in a research report on Friday, August 2nd. ValuEngine lowered shares of Metlife from a “hold” rating to a “sell” rating in a research report on Thursday, August 1st. Citigroup set a $42.00 price objective on shares of Metlife and gave the company a “sell” rating in a research report on Thursday, May 23rd. Wells Fargo & Co increased their price objective on shares of Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, July 11th. Finally, Morgan Stanley increased their price objective on shares of Metlife from $52.00 to $53.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 10th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company. Metlife has an average rating of “Hold” and an average target price of $50.91.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: Net Income

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.